Status:
NOT_YET_RECRUITING
3D Modeling for Detecting Locally Advanced Rectal Cancer With Positive Circumferential Resection Margin
Lead Sponsor:
Taichung Veterans General Hospital
Collaborating Sponsors:
National Health Research Institutes, Taiwan
Conditions:
General Surgery
Oncology
Eligibility:
All Genders
18+ years
Brief Summary
This retrospective study aims to develop an AI-assisted 3D modeling system to improve staging accuracy for stage II-III locally advanced rectal cancer (LARC). High-quality CT images from Taichung Vete...
Eligibility Criteria
Inclusion
- Diagnosed with rectal cancer, clinical stage II-III, with no distant metastasis (M0)
- Age over 18 years, with adequate physical status classified as American Society of Anesthesiologists (ASA) I-III, capable of receiving treatment and surgery
- No history of other malignancies or major diseases affecting study assessment within the past three years.
- Complete medical records, including available CT and MRI imaging.
Exclusion
- Patients with clinical stage I or IV rectal cancer.
- Age under 18 years, or physical status not meeting American Society of Anesthesiologists (ASA) I-III criteria, unable to undergo surgery or related treatment.
- Presence of other major diseases or malignancies affecting tumor assessment (e.g., diagnosis of another malignancy within the past three years, uncontrolled cardiovascular disease).
- Incomplete medical records or imaging data, including missing required CT or MRI images.
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 31 2026
Estimated Enrollment :
1500 Patients enrolled
Trial Details
Trial ID
NCT07183124
Start Date
October 1 2025
End Date
July 31 2026
Last Update
September 19 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Taichung Veterans General Hospital
Taichung, Taiwan